Latest News

Filters

Filter by tags: Radium Rosatom Clear all tag filters

5 news articles found


Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

Russia has begun tests of its new Remix (Regenerated Mixture) nuclear fuel at the MIR research reactor at the Research Institute of Atomic Reactors (NIIAR) in Dimitrovgrad. Development of REMIX fuel is part of state nuclear corporation Rosatom's strategy to enable better use of recycled uranium and plutonium on an industrial scale in pressurised water reactors.

Date: Tuesday, 15 November 2016
Original article: neimagazine.com/news/newsrussia-begins-testing-remix-fuel-5669460

Russia has started testing its new type of nuclear fuel, REMIX, at the MIR research reactor at the Research Institute of Atomic Reactors in Dimitrovgrad, which is in the Ulyanovsk region. Development of REMIX (from Regenerated Mixture) fuel is part of state nuclear corporation Rosatom's strategy to enable better use of recycled uranium and plutonium on an industrial scale in pressurized water reactors.

Date: Wednesday, 09 November 2016
Original article: world-nuclear-news.org/Articles/Russia-loads-REMIX-fuel-into-MIR-research-reactor

Russia's Siberian Chemical Combine (SCC) has fabricated experimental fuel rods with REMIX fuel at its chemical metallurgical plant, the company said. The REMIX (regenerated mixture) fuel was developed by the VG Khlopin Radium Institute in St Petersburg for Techsnadexport (Tenex), the nuclear materials trading arm of state nuclear corporation Rosatom.

Date: Tuesday, 07 June 2016
Original article: neimagazine.com/news/newsrussias-remix-fuel-will-enable-closed-fuel-cycle-4915826

Firms from Russia, Canada and the USA have been chosen to demonstrate their technology for cleaning up tritium-containing liquid radioactive waste at the Fukushima Daiichi nuclear power plant.

Date: Wednesday, 03 September 2014
Original article: neimagazine.com/news/newsfirms-selected-for-tritium-clean-up-demos-at-fukushima-4360700